✦ LIBER ✦

Corrigendum: Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

✍ Scribed by Dr. Henri Mattes; Prof. Dr. Kumlesh Kumar Dev; Dr. Rochdi Bouhelal; Dr. Carmen Barske; Dr. Fabrizio Gasparini; Dr. Danilo Guerini; Dr. Anis Khusro Mir; Dr. David Orain; Maribel Osinde; Anne Picard; Celine Dubois; Engin Tasdelen; Samuel Haessig

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 57 KB
Volume: 5
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.201090046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and Synthesis of Selective and Po

Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

✍ Dr. Henri Mattes; Prof. Dr. Kumlesh Kumar Dev; Dr. Rochdi Bouhelal; Dr. Carmen B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

Design, Synthesis and Biological Activit

Design, Synthesis and Biological Activity of Novel Dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as Potent, Selective, and Orally-Bioavailable 5-HT1D Agonists.

✍ Methvin Isaac; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 102 KB 👁 2 views

Highly Selective and Potent Agonists of

Highly Selective and Potent Agonists of Sphingosine-1-phosphate 1 (S1P1) Receptor.

✍ Petr Vachal; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 11 KB 👁 2 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase.

✍ Nigel J. Liverton; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 2 views

Aryloxazolidinediones: Identification of

Aryloxazolidinediones: Identification of Potent Orally Active PPAR Dual α/γ Agonists

✍ Ranjit C. Desai; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 70 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

ChemInform Abstract: Dimerization of Sum

ChemInform Abstract: Dimerization of Sumatriptan as an Efficient Way to Design a Potent, Centrally and Orally Active 5-HT1B Agonist.

✍ M. PEREZ; P. J. PAUWELS; C. FOURRIER; P. CHOPIN; J.-P. VALENTIN; G. W. JOHN; M. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB 👁 2 views